Webinars on timely topics such as POCT, critical care, clinical practice and regulatory updates, and common conditions including sepsis and hyperglycemia. Search for topics by keyword or category filter. You can also search by language using the tag filter.


COVID-19予防・治療 におけるマグネシウムの役割 ―最新の文献からー

山本 理 (Masaru Yamamoto,PhD)
学術部 部長
ノバ・バイオメディカル株式会社

このウェビナーの詳細を見る


Hämoglobin & Hämatokrit – Hintergrund und klinische Anwendungen

Anne Deutsch, Ph.D. M.Sc., Director Medical & Scientific Affairs Europa Nova Biomedical

Mehr Details


Dia do Rim, Creatinina e Aprendizados da Radiologia

Dr. Alexandre Oksman
Médico Hospital Nipo Brasileiro Radiologia e Diagnóstico por Imagem
Secretária de Saúde do Estado de São Paulo
Consultor médico Nova Biomedical Brasil

Saiba Mais


コロナウイルスと腎臓~COVID-19におけるAKI、CKD、および電解質(日本語解説)

Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affairs
Nova Biomedical

日本語解説:山本 理 (Masaru Yamamoto,PhD)
ノバ・バイオメディカル株式会社 学術部 部長

このウェビナーを見る


「ここまで考えたい イオン化マグネシウムの臨床使用 ~症例から学ぶ解釈と補充方法~」

演者:加藤 崇央 先生
埼玉医科大学総合医療センター 麻酔科 助教

このウェビナーを見る


Prevenção de erros pré-analíticos em testes de cuidados intensivos: K, Na, Ca ionizado, pO2 / CO-oximetria e Lactato

D. John Toffaletti, PhD
Director of ABG and CPED Labs
Duke University Medical Center

Saiba Mais


Determining Intravascular Status: What Are My Options?

Mitchell Rosner, MD, MACP
Henry B. Mulholland Professor of Medicine Chair, Department of Medicine
University of Virgininia Health System

Learn More


The importance of ketone measurements – What, Why and When?

Marcin Pacek, Ph.D., MBA
Senior Director, Medical and Scientific Affairs, Europe
Nova Biomedical

Learn More


Critical Care Monitoring von COVID-19 Patienten mit Atemnotsyndrom (RDS)

Anne Deutsch, Ph.D. M.Sc. Direktorin Medical & Scientific Affairs Europa Nova Biomedical

Mehr Details


Akutes Nierenversagen & Elektrolytanomalien bei COVID-19

Anne Deutsch, Ph.D. M.Sc. Direktorin Medical & Scientific Affairs Europa Nova Biomedical

Mehr Details


Monitoramento de Lactato para Sepse Severa ou Choque Séptico

Nam K. Tran, PhD, MS, FACB
Associate Clinical Professor & Director of Clinical Chemistry and Point-of-Care Testing
University of California, Davis

Clique aqui para se inscrever


Gestione dei pazienti con COVID-19 con difficoltà respiratoria. Utilizzo di un emogasanalizzatore con un menu completo di test point-of-care

Germano Ferrari PhD, MBA
Direttore Medical & Scientific Affairs Europa
Nova Biomedical

Clicca qui per maggiori dettagli


Ketonämie & Ketoazidose bei COVID-19

Anne Deutsch, Ph.D. M.Sc. Direktorin Medical & Scientific Affairs Europa Nova Biomedical

Mehr Details


Acute Kidney Injury and Electrolyte Abnormalities in COVID-19 Critical Illness
Dennis Begos, MD, FACS, FACRS
Associate Medical Director, Medical and Scientific Affairs
Nova Biomedical
Learn More


Richtige Therapiewahl durch interferenzfreie Glukosemessung
Anne Deutsch
Ph.D., M.Sc. Direktorin Medical & Scientific Affairs Europa
Nova Biomedical
Mehr Details


Choisir le Bon Traitement Grâce à la Mesure du Glucose sans Interférence
Germano Ferrari PhD, MBA
Directeur Europe, Medical & Scientific Affairs Nova Biomedical
Apprendre encore plus


Ketone und Diabetes mellitus: alte Probleme, neue Aspekte
Dr. Roman Iakoubov
Funktionsoberarzt, Facharzt für Innere Medizin, Endokrinologie und Diabetologie Diabetologe DDG
Klinikum Rechts der Isar, TUM
Zum Webseminar


POCT Glukose Messung bei COVID-19 Infektion: Leitlinien und Praxisempfehlungen zu Diagnose, Monitoring und Therapie
Anne Deutsch
Ph.D., M.Sc. Direktorin Medical & Scientific Affairs Europa
Nova Biomedical
Mehr Details


Medição do Magnésio Ionizado x Magnésio Total. Por que isso importa?
Bogdan Milojkovic, MD
Diretor Médico e Científico Global
Nova Biomedical
Assista aqui


POCT Glukose Messung bei COVID-19 Infektion: Spezielle Aspekte zu Vitamin C Therapie und Hämatokrit
Anne Deutsch, Ph.D., M.Sc. Director Medical & Scientific Affairs Europe Nova Biomedical Corporation
Charbel Abou-Diwan, PhD, DABCC, FAACC Director of Medical & Scientific Affairs Nova Biomedical Corporation
Sehen Sie sich diese Aufnahme hier an



Sepsis Intra-Post COVID-19 Pandemic Era
Dr Ron Daniels
NHS Consultant in Intensive Care
Executive Director of UK Sepsis Trust
Register/Learn More


Clinical Management of DKA, DKA Management Policies and Outcome (English)
Masaru Yamamoto,PhD
Director for Asia Pacific Medical & Scientific Affairs
Nova Biomedical
登録


イオン化マグネシウム測定の重要性 -JP/iMg
演者|野口 信弘 先生(Nobuhiro NOGUCHI,M.D.)
琉球大学病院 麻酔科 助教
このウェビナーを見る


ICU及び術後のイオン化マグネシウムの実際
演者:藤田 義人 先生 (Dr.Yoshihito FUJITA, M.D.,Ph.D.)
愛知医科大学病院 周術期集中治療部 麻酔科 教授(Aichi Medical University School of Medicine,
General Intensive Care Unit)
このウェビナーを見る


血液ガスでわかる!マグネシウムを理解シリーズ
演者:山本 理 (Masaru Yamamoto,PhD)学術部 部長 ノバ・バイオメディカル株式会社
1.マグネシウムの生体内での役割(11分)
2.カルシウムとマグネシウムの関係(11分)
3.イオン化マグネシウムと総マグネシウムの違い(10分)
4.マグネシウムの血中濃度と臨床症状(10分)
5.イオン化マグネシウムを追加することの患者にとっての意義(20分)
ウェビナーを視聴する


The Only Glucose Meter Specifically Approved by Health Canada for Use with Critically Ill Patients
Jingzi Sherman, MD MS CCRA
Director of Medical & Scientific Affairs
Nova Biomedical Corporation
Register/Learn More


Magnesium – From Forgotten Ion to Super Mineral in Nutrition Therapy
Nutritionist, Professor of Biochemistry Freie Universitat Berlin, Director, Institute for Prevention and Nutrition, Ismaning/Munich, Germany
Register/Learn More


COVID-19 Patienten mit Atemnot benötigen ein umfassendes Point-of-Care Test Menü zur Überwachung und Pflege
Referentin: Anne Deutsch Ph.D., M.Sc. Direktorin Medical & Scientific Affairs Europa, Nova Biomedical
Register/Learn More


Gestion des patients COVID-19 souffrant de détresse respiratoire à l’aide d’un analyseur de gaz du sang adapté aux soins intensifs
Germano Ferrari PhD, Directeur Europe, Medical & Scientific Affairs Nova Biomedical
Guarda questa registrazione qui


COVID-19パンデミックー多項目測定集中治療用アナライザーを利用したCOVID-19 呼吸困難患者管理 –JP/BGA
(2020年6月30日公開)
演者:山本 理 (Masaru Yamamoto,PhD) 学術部 部長 ノバ・バイオメディカル株式会社
このウェビナーを見る


Gestión de la glucosa Point of Care en pacientes con COVID-19 – Riesgo de interferencia del ácido ascórbico y del hematocrito
Marcin Pacek, Ph.D., MBA Senior Director, Medical and Scientific Affairs, Europe Nova Biomedical
Mira esta grabación aquí


The Clinical Impact of Tight vs Standard Glycemic Control on COVID-19 Hospitalized Patients
Bruce Bode, MD, FACE Clinical Associate Professor, Dept. of Medicine Emory University Jeffrey DuBois, PhD, HCLD/CC (ABB), FACP, VP Medical and Scientific Affairs Nova Biomedical
View this recording here


Analisi Point-of-Care di Emoglobina ed Ematocrito: Applicazioni Cliniche
Germano Ferrari PhD, MBA
Eu Director, Medical & Scientific Affairs (MASA)
Nova Biomedical
Guarda questa registrazione qui


Update Diabetes – Management des Patienten mit Diabetes
Sehen Sie sich diese Aufnahme hier an


Managing COVID-19 Patients With Respiratory Distress Using an Expanded Test Critical Care Analyzer
Bogdan Milojkovic, MD, PhD. Global Director, Medical & Scientific Affairs Nova Biomedical
View this recording here


COVID-19 Managing Respiratory Distress Patient Using an Expanded Test Blood Gas Analyser
Germano Ferrari PhD, MBA. Eu Director, Medical & Scientific Affairs (MASA), Nova Biomedical
View this recording here


Pandemia COVID-19 Controllo Delocalizzato della Glicemia. Impatto dell’Acido Ascorbico
Germano Ferrari PhD
Eu Director, Medical & Scientific Affairs (MASA) Nova Biomedical
Guarda questa registrazione qui


COVID-19 Bedside Glucose Management—Risk of Ascorbic Acid and Hematocrit Interference
Charbel Abou-Diwan, PhD, DABCC, FAACC Director of Medical & Scientific Affairs Nova Biomedical Corporation
View this recording here


COVID-19 Gestion de la glycémie au chevet des patients – Risque d’interférence avec l’acide ascorbique et l’hématocrite
Germano Ferrari PhD, MBA Eu Director, Medical & Scientific Affairs (MASA) Nova Biomedical
View this recording here


COVID-19 Bedside Glucose Management—Risk of Ascorbic Acid and Hematocrit Interference
Speaker: Charbel Abou-Diwan, PhD, DABCC, FAACC Director of Medical & Scientific Affairs Nova Biomedical Corporation
View this recording here


COVID-19 Bedside Glucose Management—Risk of Ascorbic Acid and Hematocrit Interference
Speaker: Germano Ferrari PhD, MBA Eu Director, Medical & Scientific Affairs (MASA) Nova Biomedical
View this recording here


Magnesium citrate supplementation in obese, untreated or newly diagnosed prediabetic subjects without hypomagnesemia: a 12-week, placebo-controlled, double-blinded pilot trial
Speaker: Dr. Tanja Werner / Leitung Medizin und Wissenschaft / Protina Pharmazeutische GmbH
View this recording here


Magnesium citrate supplementation in obese, untreated or newly diagnosed prediabetic subjects without hypomagnesemia: a 12-weeks, place bo-controlled, double-blinded pilot trial
Speaker: Dr. Tanja Werner
Leitung Medizin und Wissenschaft
Protina Pharmazeutische GmbH
View this recording here


忘れられた電解質 マグネシウム~イオン化マグネシウムを理解~-JP/iMg
演者:小山 薫 先生(Dr.Kaoru KOYAMA,M.D.,Ph.D.)
埼玉医科大学総合医療センター 麻酔科 教授(Saitama Medical Univ. dept. of Anesthesiology)
座長: 瀬尾 勝弘 先生(Dr.Katsuhiro SEO, M.D.)
小倉記念病院 副院長/麻酔科・集中治療部 主任部長(Kokura kinen Hospital)
このウェビナーを見る


周産期におけるマグネシウム:多彩な役割とイオン化マグネシウム測定の意義 -JP/iMg
演者:照井 克生 先生 (Dr.Katsuo TERUI,M.D.,Ph.D.)
埼玉医科大学総合医療センター 産科麻酔科 教授(Saitama Medical Univ. dept. of Anesthesiology)
座長:祖父江 和哉 先生 (Dr.Kazuya SOBUE, M.D.,Ph.D)
名古屋市立大学大学院医学研究科 麻酔科学・集中治療医学分野(Nagoya City Univ.Graduate School of Medical Sciences)
このウェビナーを見る


ベッドサイドにおけるイオン化マグネシウム測定の有用性 -JP/iMg
演者:加藤 崇央 先生(Dr.Takao KATO,M.D.)
埼玉医科大学総合医療センター 麻酔科 (Saitama Medical Univ. dept. of Anesthesiology)
座長:山浦 健 先生(Dr.Ken YAMAURA, M.D.,Ph.D.)
九州大学大学院 医学研究院外科学講座 麻酔・蘇生科分野 教授(Kyushu University Department of Anesthesiology & Critical Care Medicine)
このウェビナーを見る


急性期における電解質管理の盲点 イオン化マグネシウム測定の重要性-JP/iMg
演者:秋吉 浩三郎 先生 (Dr. Kozaburo AKIYOSHI,M.D.,Ph.D.)
福岡大学 医学部 麻酔科 (Fukuoka Univ. dept. of Anesthesiology)
座長:小山 薫 先生 (Dr.Kaoru KOYAMA, M.D.,Ph.D)
埼玉医科大学総合医療センター麻酔科(Saitama Medical Univ. dept. of Anesthesiology)
このウェビナーを見る


Il percorso storico per una misurazione sicura del Glucosio nel POCT
Germano Ferrari, PhD
Eu Director, Medical & Scientific Affairs (MASA)
Nova Biomedical
Guarda questa registrazione qui


Il problema delle interefenze nella misurazione del Glucosio nel POCT
Germano Ferrari, PhD
Eu Director, Medical & Scientific Affairs (MASA)
Nova Biomedical
Guarda questa registrazione qui


Il processo emogas-analitico nelle diverse fasi: pre-analitica, analitica, post-analitica. Modulo 1: fase pre-analitica
Dottoressa Erica Rampoldi, MD
Specialità in Biochimica Clinica e Biologia molecolare
Ospedale di Legnano (MI) ASST Ovest Milanese
Guarda questa registrazione qui


Il processo emogas-analitico nelle diverse fasi: pre-analitica, analitica, post-analitica. Modulo 2: fase analitica e post-analitica
Dottoressa Erica Rampoldi, MD
Specialità in Biochimica Clinica e Biologia molecolare
Ospedale di Legnano (MI) ASST Ovest Milanese
Guarda questa registrazione qui


Overcoming confounding issues in point-of-care glucose measurement
Presenter 1:
Kathleen Dungan, MD, MPH
Associate Professor, Division of Endocrinology, Diabetes and Metabolism
Ohio State University Wexner Medical Center
Presenter 2:
Kathleen Wyne, MD, PhD
Associate Professor, Division of Endocrinology, Diabetes and Metabolism Director,
Type I Diabetes Center Ohio State University Wexner Medical Center
View this recording here


Ionized Magnesium Versus Total Magnesium Measurement: Does it Matter?
Bogdan Milojkovic, MD
Global Director, Medical and Scientific Affairs
Nova Biomedical
View this recording here


Les avantages de la mesure du taux de cétones dans le sang total
Charbel Abou-Diwan, D(ABCC), FACC
Responsable du département des affaires médicales & scientifiques – Nova Biomedical Corporation
View this recording here



Consequences of FDA Changes to Critically Ill Bedside Glucose Testing Regulations
Natalie Mazina / Healthcare & Pharmacy Attorney
Jeffrey DuBois, PhD / VP Medical and Scientific Affairs
View this recording here




重症患者におけるイオン化マグネシウム(iMg) 測定の重要性-JP/iMg
Evan Ntrivalas, MD, PhD Director, Medical and Scientific Affairs, Nova Biomedical
日本語解説 山本 理 (Masaru Yamamoto, PhD) 学術部 部長 / ノバ・バイオメディカル株式会社
このウェビナーを見る



Preventing Pre-analytical Errors in Critical Care Testing: K, Na, ionized Ca, PO2 / CO-oximetry, and lactate
John Toffaletti / Lab Director; Professor of Pathology
View this recording here


Lactate Monitoring for Severe Sepsis and Septic Shock: Are All Lactate Measurements the Same?
Nam K. Tran, PhD, MS, FACB, Associate Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine, University of California, Davis
View this recording here


The Sepsis Epidemic: New Sepsis Definitions and Evidenced-Based Treatment
Ron Daniels, BEM, NHS Consultant in Critical Care and Anaesthesia, Co-Founder and Chief Executive, UK Sepsis Trust and CEO, Global Sepsis Alliance
View this recording here


The Confusing Conundrum of Collecting and Measuring Glucose in Neonates
Martha Lyon, PhD, DABCC, FACB, Clinical Biochemist/Clinical, Associate Professor, Royal University Hospital, Saskatoon
View this recording here


The Clinical Impact of Improved Glucose Monitoring in Neonatal Intensive Care Pediatric Setting
Khosrow Adeli, PhD, FCACB, NACB, DABCC, Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University of Toronto
View this recording here


The Diagnostic Approach to Patients with Sepsis
Evan Ntrivalas, MD, PhD / Director of Medical and Scientific Affairs / Nova Biomedical
View this recording here


Bedside glucose testing in critically ill patients: The importance of improved accuracy
Martha E. Lyon, PhD, DABCC, FACB / Clinical Biochemist / Royal University Hospital
View this recording here


Clinical Impact of Blood Glucose Monitoring Accuracy in Critical Care
Nam K. Tran, PhD, MS, FACB-Associate Clinical Professor & Director of Clinical / Chemistry and Point-of-Care Testing
View this recording here


Role of ionized magnesium in the care of the ICU patient: Implications for point of care, pharmacy utilization and clinical outcomes
Melissa L. Thompson Bastin, PharmD, BS, BCPS / Critical Care Pharmacist / Medical Intensive Care Unit / Pulmonary / University of Kentucky Health Care / University of Kentucky College of Pharmacy
View this recording here


Glucose meter use in critically ill patients: Why improved meter accuracy may lead to better ICU outcomes
Brad S. Karon, MD, PhD / Professor of Laboratory Medicine & Pathology / Director, Point of Care Testing & Hospital Clinical Labs / Mayo Clinic, Rochester, MN
View this recording here


Choosing the right sample for glucose POCT: BRAVE criteria
Steven Cotten, PhD, DABCC, NACB, Assistant Professor Pathology & Director of Chemistry and Toxicology, Ohio State University / Wexner Medical Center
View this recording here


High Dose Vitamin C Therapy in Critically Ill Patients: False Hyperglycemia Associated with POC Glycemic Management
Alexander H. Flannery, PharmD, BCCCP, BCPS, Assistant Professor, Department of Pharmacy Practice and Science Director, PGY2 Critical Care Residency, University of Kentucky HealthCare and College of Pharmacy
View this recording here


The Importance of Measuring Ionised Magnesium in Critically Ill Patients
Andrei Malic (PhD), Clinical Communications Director, Medical and Scientific Affairs, Nova Biomedical
View this recording here


The Importance of Measuring Ionized Magnesium in Critically Ill Patients
Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
View this recording here


Bedside Glucose Monitoring – Is it Safe for Critically Ill Patients?
Andrei Malic, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
View this recording here


New Regulatory and Accreditation Issues that Affect Hospital Glycemic Management Programs
Jeffery A. DuBois, PhD, HCLD/CC (ABB), FACP, VP Medical and Scientific Affairs, Nova Biomedical
View this recording here


Can Point-of-Care Creatinine Testing Reduce Contrast-Induced Acute Kidney Injury (CI-AKI) in STEMI Patients Treated with PPCI?
Thomas Keeble, MBBS, BSc, MRCP, MD, Consultant Cardiologist, Southend Hospital, Essex Cardiothoracic Centre, and Senior Clinical Fellow, Anglia Ruskin University
View this recording here


Clinical Impact of Blood Glucose Monitoring System Accuracy in Critical Care
Nam K. Tran, PhD, MS, FACB, Assistant Clinical Professor, Director of Clinical Chemistry and Point-of-Care Testing, Department of Pathology and Laboratory Medicine, University of California, Davis
View this recording here


Point-of-Care Glucose in Critically Ill Patients– The Importance of Glucose Meter Accuracy
Arthur H. Combs, MD, FCCP, FCCM, President, FutureTech Strategies, Inc., and Evan Ntrivalas, MD, PhD, Director, Medical and Scientific Affairs, Nova Biomedical
View this recording here


Glucose Meters and Glycemic Control: Does Meter Error Impact Glycemic Control Outcomes?
Brad S. Karon, MD, PhD, Associate Professor of Laboratory Medicine and Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic
View this recording here


毛細血管全血 – 重症患者ケア環境における血糖モニタリングにふさわしい検体か) -JP/Glu
山本 理 (Masaru Yamamoto,PhD)  学術部 部長  ノバ・バイオメディカル株式会社
このウェビナーを見る


院内における血糖管理に影響を及ぼす新たな規制および認証評価上の問題点(米国の現状を参考に) -JP/Glu
山本 理 (Masaru Yamamoto,PhD) 学術部 部長 / ノバ・バイオメディカル株式会社
このウェビナーを見る


新生児治療におけるイオン化マグネシウムの有用性-JP/iMg
豊島 勝昭 先生  新生児科部長  神奈川県立こども医療センター
山本 理 (Masaru Yamamoto,PhD)  学術部 部長  ノバ・バイオメディカル株式会社
このウェビナーを見る


Monitoraggio del Glucosio ematico: E’ sicuro per i pazienti critici?
Germano Ferrari, PhD
Direttore degli Affari Medici e Scientifici – Europa
Nova Biomedical
Guarda questa registrazione qui


Misura del Lattato in Point-of-care: uno strumento essenziale nella gestione del paziente settico
Germano Ferrari, PhD
Direttore degli Affari Medici e Scientifici – Europa
Nova Biomedical
Guarda questa registrazione qui


L’importanza della misurazione del magnesio ionizzato
Germano Ferrari, PhD
Direttore degli Affari Medici e Scientifici – Europa
Nova Biomedical
Guarda questa registrazione qui


Ionisiertes Magnesium: Was haben kardiovaskulare Erkrankungen, Diabetes mellitus, Sport und Stress, gastrointestinale Krankheiten, renale Verluste, ZNS-Erkrankungen sowie Radio- und Chemotherapie gemeinsam? Finden Sie es heraus.
Prof. Dr. med. Klaus Kisters
St. Anna-Hospital-St.Elisabeth Gruppe-Kath. Kliniken Rhein-Ruhr
Sehen Sie sich diese Aufnahme hier an


Analyse von iMg mit Blutgas- und Bufferwerten: eine besonders genaue Bestimmung Analysis of iMg with bloodgas and buffer values: a particularly exact determination
Univ. Prof. Dr. Dr. hc Sepp Porta
Institut für Angewandte Stressforschung
Sehen Sie sich diese Aufnahme hier an


Bestimmung des ionisierten Calciums im Rahmen der Citratdialyseüberwachung
PD Dr. med. Dipl. Biol. Astrid Petersmann
Oberärztin sowie
Stellvertreterin des Direktors des Instituts für Klinische Chemie und Laboratoriumsmedizin
Universitätsmedizin der Ernst-Moritz Arndt, Universität Greifswald
Sehen Sie sich diese Aufnahme hier an


Blutzuckermessung in der Pädiatrie – Fallstricke und klinische Relevanz
Dr. med. Sven Armbrust
Chefarzt der Kinder- und Jugendklinik
Dietrich-Bonhoeffer-Krankenhaus, Neubrandenburg
Sehen Sie sich diese Aufnahme hier an


Diabetische Ketoazidose (DKA) Neue Erkenntnisse für DKA-Diagnose und -Management im Krankenhaus
PD Dr. med. Helmut Walter
Diabetologe, bis 2013 Oberarzt an der Med. Klinik 4, Klinikum Nürnberg Süd
Internistische Schwerpunktpraxis Gunzenhausen
KKL – Internistische Praxis, Endokrinologische Praxis, Diabetische Schwerpunktpraxis Nürnberg
Sehen Sie sich diese Aufnahme hier an


Präanalytik in der patientennahen Sofortdiagnostik (POCT)
PD Dr. Dr. Kathrin Schlatterer-Krauter Laborleitung
St. Gertrauden-Krankenhaus, Berlin
Sehen Sie sich diese Aufnahme hier an


Bedeutung des ionisierten Magnesiums
Prof. Dr. med. Klaus Kisters
Chefarzt an der Medizinischen Klinik
St. Anna Hospital in Herne seit
2001 Professor an der Universität Münster
Sehen Sie sich diese Aufnahme hier an


Die Rolle von HbA1c, Lipiden und Nierenfunktionsparametern bei der Kontrolle des Diabetes-Managements
PD Dr. med. Susanne Reger-Tan
Klinik für Endokrinologie und Stoffwechselerkrankungen
Universitätsklinikum Essen
Transplantations-Endokrinologie und -Diabetologie (TRENDE) Zertifiziertes Diabeteszentrum DDG (Typ 1 und 2)
ENETS Center of Excellence
Zentrallabor – Forschung und Lehre
Sehen Sie sich diese Aufnahme hier an


Bedeutung des ionisierten Magnesiums und der Nierenfunktionsparameter
Prof. Dr. med. Klaus Kisters
Chefarzt an der Medizinischen Klinik
St. Anna Hospital in Herne
seit 2001 Professor an der Universität Münster
Sehen Sie sich diese Aufnahme hier an


Das Management von Dysglykämie mit POCT: Geräte-Technologie und -Performance Betrachtung
Georg Montanus / Dipl. Ing. / Medizintechnik (FH)/ Produktspezialist / Nova Biomedical GmbH / Mörfelden-Walldorf
Sehen Sie sich diese Aufnahme hier an


Glu-床旁血糖监测-对重症病人来说安全吗?
裘玮 Wei Qiu
医学科学事物部中国区总监
美国 Nova Biomedical 公司
View this recording here


iMg -对危重病人进行游离镁离子检测的重要性
裘玮 Wei Qiu
医学科学事物部中国区总监
美国 Nova Biomedical 公司
View this recording here


Análise de Gases Sanguíneos: Interpretação Básica do Equilíbrio Ácido-Base
Federico Montalegre-Golcher, DVM, MS, PhD, PCBE
Diretor Médico e Científico América LatinaNova Biomedical
View this recording here


Lactato como Biomarcador Laboratorial para Sepse
Federico Montalegre-Golcher, DVM, MS, PhD, PCBE
Diretor Médico e Científico América Latina Nova Biomedical
View this recording here


Por que incluir magnésio ionizado (iMg) no menu de testes laboratoriais?
Federico Montalegre-Golcher, DVM, MS, PhD, PCBE
Diretor Médico e Científico América Latina Nova Biomedical
View this recording here


Análise e Importância Clínica dos Biomarcadores de Função Renal pelo teste Point-of-Care (POC): Creatinina Sérica e a Taxa de Filtração Glomerular Estimada
Federico Montalegre-Golcher, DVM, MS, PhD, PCBE
Diretor Médico e Científico América Latina Nova Biomedical
View this recording here


Impacto Clínico de la Presición de los Medidores Portátiles de Glucosa en Cuidados Intensivos
Federico Montealegre, DVM, MS, PhD, PhD
Director, Departamento Medico y Científic
View this recording here


¿Porqué debemos incluir el magnesio ionizado (iMg2+) en el menú de pruebas laboratoriales?- ES iMg –
Federico Montealegre-Golcher, DVM, PhD, MS,
Director, MASA LATAM
Nova Biomedical
View this recording here


Analyse d’un trouble acide-base selon la méthode qualitative classique et l’approche quantitative de Fencl-Stewart
Professeur Jacques Levraut-Chef du Département de Médecine d’Urgence-Hôpital Pasteur 2,
Nice-Professeur de médecine d’urgence à l’université Nice Sophia –Antipolis-Chef du Département de Médecine d’Urgence à l’hôpital Pasteur 2 à Nice
View this recording here


La surveillance de la glycémie est-elle fiable pour les patients en soins intensifs?
Charbel Abou-Diwan, PhD, D(ABCC), F(ACB)
Directeur Affaires médicales et scientifiques
Nova Biomedical
View this recording here


Mesure de la cétonémie comme outil de triage aux Urgences?
Professeur Jacques Levraut
Professeur de médecine d’urgence à l’université Nice Sophia –Antipolis
Chef du Pôle Urgences-SAMU-SMUR de l’hôpital l’Archet 2 à Nice
View this recording here


L’importance de mesurer le magnésium ionisé chez les patients en état critique
Germano Ferrari PhD
Directeur Européen, Affaires Médicales et Scientifiques, Nova Biomedical
View this recording here